«If histamine is actually an active player in Tourette's syndrome, it really would open up a
whole new avenue of treatment» involving drugs that boost histamine, says Jeremiah Scharf, a behavioral neurologist and neurogeneticist at Harvard Medical School in Boston.
They suggest that similarities between the RNA of some of the patients» tumors could open up
new avenues of treatment.
Understanding Notch signaling effects in this pediatric solid tumor can potentially lead to
new avenues of treatment.
These new avenues of treatment offer veterinarians, and clients, options and alternatives to give our animal companions the best quality of life.